80 FR 17459 - Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 62 (April 1, 2015)

[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)]
[Notices]
[Page 17459]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: C1-2015-06486]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Start-Up Exclusive Evaluation Option License 
Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-
Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the 
Treatment of Human Cancers

Correction

    In notice document 2015-06486 appearing on pages 15226-15227 in the 
issue of Monday, March 23, 2015 make the following correction:
    On page 15226, in the third column, under the DATES heading, in the 
last line, ``April 6, 2015'' should read ``April 7, 2015''.

[FR Doc. C1-2015-06486 Filed 3-31-15; 8:45 am]
 BILLING CODE 1505-01-P